REGISTERED
on 09 Apr 2024
Last Applicant/ Owned by
2533 S. Coast Highway 101, Suite 210
Cardiff
CA
92007
Serial Number
97457119 filed on 14th Jun 2022
Registration Number
7356577 registered on 09th Apr 2024
Correspondent Address
Alyssa M. Worsham
Filing Basis
1. intent to use
2. filed as use application
3. use application currently
Disclaimer
NO DATA
VIRACTA
Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines in the nature of pharmaceutical research; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing medical information, consultancy and advisory services; providing a website via a global computer network featuring medical information in the fields of cancer, viral-associated cancers and other viral associated diseases and disorders
First Use Date in General
24th Feb 2021
First Use Date in Commerce
24th Feb 2021
Class [042]
Computer & Software Services & Scientific Services
Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines in the nature of pharmaceutical research; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of biological and chemical preparations for the treatment of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of pharmaceutical products, preparations and compounds for the treatment of viral-associated cancers and other viral associated diseases and disorders; DNA screening and analysis services for scientific research purposes; research and development of pharmaceutical products, preparations and compounds for T-cell adoptive transfer, immune reconstitution, and cell-based immunotherapy; research and development of pharmaceutical products, preparations and compounds for the treatment of cancer, tumors, and hematological malignancies
First Use Date in General
24th Feb 2021
First Use Date in Commerce
24th Feb 2021
Class [005]
Pharmaceutical Products
Pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases and disorders; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies; all of the foregoing containing antivirals
First Use Date in General
30th Sep 2023
First Use Date in Commerce
30th Sep 2023
Mark Details
Serial Number
No 97457119
Mark Type
No Service Mark
Attorney Docket Number
No 34547-TM1008
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
| 06th Mar 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Mar 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 05th Feb 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 05th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 16th Jan 2024 | TEAS STATEMENT OF USE RECEIVED |
| 16th Jan 2024 | USE AMENDMENT FILED |
| 25th Jul 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 30th May 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |